Tianjin Zhengli Technology Co., Ltd. announced that it has received $15,700,000 in a round of funding on December 29, 2021. The transaction included participation from 3E Bioventures Capital, HPE and Eyebright Medical Technology (Beijing) Co., Ltd.
Eyebright Medical Technology (Beijing) Co., Ltd.
Equities
688050
CNE1000041J5
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
134.6 CNY | -2.67% | +4.52% | -21.76% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.76% | 2.01B | |
-1.84% | 23.52B | |
-9.62% | 16.27B | |
+5.69% | 13.45B | |
+6.62% | 9.68B | |
+12.20% | 1.8B | |
+30.15% | 1.62B | |
+8.37% | 570M | |
0.00% | 524M | |
+29.68% | 96.53M |
- Stock Market
- Equities
- 688050 Stock
- News Eyebright Medical Technology (Beijing) Co., Ltd.
- Tianjin Zhengli Technology Co., Ltd. announced that it has received $15.7 million in funding from 3E Bioventures Capital, Eyebright Medical Technology Co., Ltd. and another investor